Shares of clinical-stage biotech firm Genenta Science S.p.A. (GNTA) plunged 43.4% in early Monday trading after announcing a $15 million private placement. The stock traded as high as $6.20. Proceeds will be allocated for working capital and general corporate purposes, demonstrating strong investor interest.